Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Respond to Pharmacist's GDR Recommendation for Psychotropic Medication

Rosemead, California Survey Completed on 05-23-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to respond to a consultant pharmacist's recommendation for a gradual dosage reduction (GDR) of quetiapine for a resident diagnosed with dementia and psychosis. The pharmacist made the recommendation on 2/5/25, and although the facility left a message with the psychiatrist on 2/9/25, there was no documented response from the physician or evidence of further follow-up. The resident's clinical record did not contain documentation of psychiatric care or any indication that a physician considered the GDR request, approved a lower dose, or provided a resident-specific clinical rationale for not attempting a GDR. Additionally, the facility did not clearly identify or document the specific behavioral issues related to the resident's use of quetiapine. The problematic behaviors listed in the physician's order and informed consent documentation differed from those in the care plan and medication administration record, making the rationale for continued use of quetiapine unclear. The Director of Nursing confirmed that a GDR was not performed and that there was no documentation to indicate that a GDR attempt was clinically contraindicated, as required by facility policy.

An unhandled error has occurred. Reload 🗙